Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this research study is to examine the role oxidants, substances produced in the blood that can damage blood vessel function, may play in blood vessel function in healthy individuals as well as individuals with mental health disorders (posttraumatic stress disorder (PTSD) and/or generalized anxiety disorder (GAD)).
Study #1 is made up of three sessions done on three separate days and the entire study can be completed in as little as two weeks. All testing sessions will take place at the Exercise Physiology Research Laboratory. Volunteers will be asked to participate in one initial testing session (Visit 1) lasting < 1 hour that will help make them more familiar with the study equipment and procedures, determine body measures (height, weight, body fat), determine the maximum strength of their forearm and calf, and require one blood draw. The following two testing sessions (Visits 2 and 3) with each session lasting between 2-3 hours that will involve multiple tests designed to determine the health of their blood vessels. For Visit #2 they will be randomly given either antioxidant pills or placebo pills to determine the effect of oxidants on blood vessel health. For Visit #3, they will be given whatever set of pills (antioxidant or placebo) that they did not receive during Visit #2.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Antioxidant then Placebo | Experimental | Subjects will ingest an antioxidant cocktail prior to their second visit and a placebo prior to third second visit |
|
| Placebo then Antioxidant | Experimental | Subjects will ingest a placebo prior to their second visit and an antioxidant cocktail prior to their third visit. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Antioxidant | Dietary Supplement | Subjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol). |
| Measure | Description | Time Frame |
|---|---|---|
| Arm Vascular Function at Rest (Flow Mediated Dilation Test) | Change in Brachial Artery Dilation from Baseline Values | Baseline to the end of the final visit, about 2 weeks |
| Leg Vascular Function (Passive Leg Movement Test) | Change in Leg Blood Flow Values from Baseline | Baseline to the end of the final visit, about 2 weeks |
| Arm Vascular Function in Response to Exercise (Handgrip Exercise Test) | Change in Brachial Artery Dilation from Baseline Values | Baseline to the end of the final visit, about 2 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ryan Garten, PhD | Contact | (804) 828-1948 | rsgarten@vcu.edu |
| Name | Affiliation | Role |
|---|---|---|
| Ryan Garten, PhD | Virginia Commonwealth University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Virginia Commonwealth University | Recruiting | Richmond | Virginia | 23298 | United States |
Not provided
| ID | Term |
|---|---|
| D016491 | Peripheral Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D013313 | Stress Disorders, Post-Traumatic |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000975 | Antioxidants |
| ID | Term |
|---|---|
| D001685 | Biological Factors |
| D045504 | Molecular Mechanisms of Pharmacological Action |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Dietary Supplement | Subjects will ingest placebo (microcrystalline cellulose) pills. |
|
| D020011 | Protective Agents |
| D045505 | Physiological Effects of Drugs |
| D020313 | Specialty Uses of Chemicals |